Novartis to spin out Alcon ophthalmic subsidiary

Novartis to spin out Alcon ophthalmic subsidiary

Source: 
Mass Device
snippet: 

Novartis (NYSE:NVS) said today that it’s planning to spin its Alcon ophthalmology subsidiary into a publicly traded company after years of speculation that it wanted to sell the ill-starred division.